JPRN-UMIN000054201招募中Unknown
ow-dose L-DOPA treatment for drug-induced dystonia - Low-dose L-DOPA treatment for drug-induced dystonia
Osaka Neurological Institute0 个研究点目标入组 9 人开始时间: 2024年4月19日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 120years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Other cases considered unsuitable for this study
研究者
相似试验
招募中
Unknown
Efficacy and safety of levodopa in dystonia due to neurological Wilson disease, an open labeled placebo controlled randomized controlled trialCTRI/2024/02/062899Dr Jayantee Kalita
招募中
不适用
Pathophysiology of L-Dopa responsive Dystonia and other monogenetic disordersDRKS00019110Zentrum für Kinder-und Jugendmedizin Heidelberg Sektion für Neuropädiatrie und Stoffwechselmedizin50
进行中（未招募）
1 期
Dopamine on top of standard treatment for patients with exacerbation of Heart Failure, at home situatioEUCTR2011-002236-92-NLMaatschap cardiologie Isala klinieken Zwolle110
招募中
3 期
Dopamine on top of standard treatment for patients with exacerbation of Heart Failure, at home situatioCongestive Heart Failureheart failureNL-OMON35847Isala Klinieken110
已完成
3 期
Effects on the pharmacokinetics of L-DOPA formulation by Proton pump inhibitors in patients with Parkinson's diseaseParkinson's diseases diseaseJPRN-UMIN000022529tano National Hospital, National Hospital Organization8